US Patent 10837016 Modulation of huntingtin expression
Patent 10837016 was granted and assigned to Ionis Pharmaceuticals on November, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 26, 2020
0
Date of Patent
November 17, 2020
0
Patent Applicant
Patent Application Number
16801431
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10837016 Modulation of huntingtin expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
